CD8A and neoplasm: Given the efficacy of αCD45-Cyt therapy, we performed gene set enrichment analysis (GSEA) to probe whether αCD45-Cyt therapy induces an ‘antiviral-like’ signature within the tumor-reactive TDLN CD8+ compartment.